Company: CMND
Filing Date: 2025-01-22
Form Type: 20-F
Source: 0001213900-25-005490
Chunk: 180

Company: Clearmind Medicine Inc.
Filing Date: 2025-01-22
Form: 20-F
Item: Item 6
Chunk 180
---
 the minister of
foreign affairs and minister of transportation. From 2012 until 2015, Ms. Kiron-Revach served as CEO of Hamil 38 - the Israeli Center
for National Master Plan to Strengthen Existing Building in the Face of Earthquakes, Tama 38 Ltd. and as an attorney at Tabakman &
Co. Law Firm. In 2007, Ms. Kiron-Revach founded Eliya - AB and served as its chief executive officer until 2010. Ms. Kiron-Revach
holds an LL. B. from the Netanya Academic College and is a licensed attorney in Israel.

Family Relationships

There are no family relationships between any members
of our executive management and our directors.

Scientific Advisory Board

We have a Scientific Advisory Board of eight researchers
in the field(s) of: Psychiatry, Neuroscience, Neuropsychopharmacology, addiction, alcoholism and Clinical and Regulatory Affairs. We consult
with the members of our Scientific Advisory Board on a regular basis.

Prof. Michael Davidson, MD has published
over 350 articles in peer reviewed prestigious journals in the area of Psychiatry and of Alzheimer’s disease, including on development
of novel treatments. Previously he was Department Chairman at the Tel Aviv University and Chief Editor of the European Neuropsychopharmacology
journal. He is currently Chairman of the department of psychiatry at the Nicosia University medical school, the President of the Alzheimer
Center in Israel, and actively involved in drug development.

Prof. Alon Friedman, MD, PhD is Professor
of Neuroscience at both Ben-Gurion University of the Negev (BGU) in Beersheba, Israel, and Dalhousie University, Halifax, Canada. Prof.
Friedman, is best known for his discoveries of the link between blood - brain barrier dysfunction (BBBd) and neuropathologies, and
the mechanisms underlying BBBd-related diseases. His team developed novel imaging modalities for the diagnosis of BBBd in neuro-psychiatric
disorders.

Prof. Gal Yadid, PhD is an expert in neuropsychopharmacology,
and is a Lab Chief in the Brain center of the Bar Ilan University. His field research and treatment development for reward-related psychiatric
disorders, specifically Addiction, PTSD and depression. His research moved from preclinical (using unique animal models) to clinical applying
various methods (behavioral, cognitive, histochemical, neurochemical, genetic / epigenetic,